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Digestive System and Therapy”Grace Liejun GuoAssociate Prof. Grace Liejun Guo is a tenured faculty in the
Department of Pharmacology and Toxicology in the School of
Pharmacy at the Rutgers University in New Jersey, USA.
Dr. Guo graduated from the West China University of Medical
Sciences in 1993. In 1997, Dr. Guo obtained a MS degree ininese Pharmaceutical Association and Institute of Materia
ts reserved.
16/j.apsb.2015.03.004Immunology at the University of Arkansas for Medical Science, in
2001, a Ph.D. degree in Toxicology at theUniversity ofKansasMedical
Center, and from 2001 to 2004, the post-doctoral training at the NCI,
NIH. Dr. Guo has been a tenured faculty at the Department of
Pharmacology, Toxicology and Therapeutics at the University of
Kansas Medical Center (2004–2012), and a tenured faculty at the
Rutgers University (2012–present).
For the last two decades, Dr. Guo has determined the roles of
nuclear receptors and signaling pathways that are critical for liver
homeostasis and metabolism, including farnesoid X receptor
(FXR), pregnane X receptor, constitutive androstane receptor,
ﬁbroblast growth factor 15/19 and bile acids. The highlights of
Dr. Guo's research ﬁndings include understanding the cellular and
molecular mechanism by which tissue-speciﬁc FXR functions to
regulate bile acid homeostasis, transcriptional regulation of drug
metabolism and transport, non-alcoholic hepatosteatosis, liver and
colon carcinogenesis, and liver regeneration.
Dr. Guo has published over 75 peer-reviewed research and
review articles on nuclear receptors and their regulation of
liver and intestine functions. As the PI or Co-I on several NIH
funding, Dr. Guo's laboratory has laid the ground work by
determining the role of intestinal FXR in regulating liver
functions.
Dr. Guo is a member of several scientiﬁc societies, scientiﬁc
reviewer for the US and Italian NIH and private foundations,
editorial board member and ad hoc manuscript reviewers for
numerous prestigious journals, and invited speakers for national
and international lectures and meetings.Medica, Chinese Academy of Medical Sciences. Production and hosting by
Editor proﬁle92Huiping ZhouDr. Huiping Zhou received the BS and MS degrees from China
Pharmaceutical University, Nanjing, China and a Ph.D. from
University of Kentucky, Lexington, Kentucky, USA. After one
year of postdoctoral training at the College of Pharmacy, Uni-
versity of Kentucky, Dr. Zhou was recruited to the Medical
College of Virginia, Virginia Commonwealth University as a
Senior Research Scientist in the Department of Internal Medicine/
Gastroenterology Division. Currently, Dr. Zhou is a tenured
Associate Professor in the Department of Microbiology and
Immunology, Virginia Commonwealth University, Richmond,
Virginia, USA.Dr. Zhou has more than 20 years' research experience in
pharmacology and molecular biology. Her current research focuses
on studying ER stress and inﬂammation in metabolic diseases and
drug-induced liver injury. For the past 10 years Dr. Zhou's
laboratory has been investigating the cellular and molecular
mechanisms of HIV protease inhibitor-induced dyslipidemia and
atherosclerosis by using in vitro cell culture systems and in vivo
animal models. Her lab ﬁrst identiﬁed that the unfolded protein
response (UPR) plays an important role in HIV PI-induced
inﬂammation and dysregulation of lipid metabolism in macro-
phages and hepatocytes. Recently, her lab ﬁrst identiﬁed that the
conjugated bile acid–induced activation of sphingosine-1-
phopsphate receptor 2 plays an important role in regulating hepatic
lipid metabolism and cholangiocyte proliferation.
Dr. Zhou has published over 100 SCI peer-reviewed articles and
reviews in prestigious journals such as Hepatology, Cell Metabo-
lism, Gastroenterology, Journal of Lipid Research, Molecular
Pharmaceutics, Journal of Biological Chemistry, Journal of
Molecular and Cellular Cardiology, Journal of Cellular and
Molecular Medicine and PLoS One. Her research has been
continuously funded by the National Institute of Health (NIH),
Veterans Merit Award, National Science Foundation of China and
pharmaceutical companies. Dr. Zhou is an internationally well-
known expert in the ﬁeld of ER stress, hepatic lipid metabolism
and bile acid signaling. She is a current member of the VA Merit
Award Gastroenterology Study Section. She reviewed grant
applications for several NIH study sections, the Natural Science
Foundation of China and several other private funding agencies. In
addition, she serves as an Editorial Board member for several
prestigious journals and ad hoc reviewer for more than 50 top-
notch journals. She was invited to present her research at many
international meetings, universities and institutes. During the last
eight years, Dr. Zhou has trained many Ph.D. students and
postdoctoral fellows including visiting students from China. Most
of them are currently holding faculty positions in universities.
